
Minride P M 1mg/500mg/15mg Tablet
Marketer
Morecare Pharmatec Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Minride P M 1mg/500mg/15mg Tablet
Combiflor 1mg/500mg/15mg tablets effectively manage blood glucose in adults with type 2 diabetes. This triple-action medication, used alongside diet and exercise, enhances insulin efficacy, resulting in improved blood sugar control. Dosage and frequency should strictly adhere to your physician's instructions; always take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; overdose risks hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals elevates hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function assessment will be conducted before initiating therapy. Limit alcohol consumption to mitigate potential side effect intensification.
Primary Ingredients of Minride P M 1mg/500mg/15mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Minride P M 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Minride P M 1mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. The Minride P M 1mg/500mg/15mg Tablet should be administered with a meal.
Common Side effects of Minride P M 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Minride P M 1mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Minride P M 1mg/500mg/15mg Tablet with food.
How Minride P M 1mg/500mg/15mg Tablet works:
Minride P M tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose. Metformin, a biguanide, acts triply: it diminishes hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Minride P M 1mg/500mg/15mg Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Minride P M 1mg/500mg/15mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Minride P M 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Minride P M 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is necessary. This medication is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Minride P M 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Minride P M 1mg/500mg/15mg tablets are contraindicated in individuals with severe liver dysfunction.
What if you forget to take Minride P M 1mg/500mg/15mg Tablet :
Should you forget a Minride P M 1mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Minride P M 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Type of Therapy | Diabetes Management |
